Aminoalkanol derivatives

Details for Australian Patent Application No. 2004283844 (hide)

Owner Novartis AG

Inventors Oberer, Lukas; Kusters, Ernst; Sedelmeier, Gottfried

Agent Davies Collison Cave

Pub. Number AU-B-2004283844

PCT Pub. Number WO2005/040091

Priority 0324210.4 15.10.03 GB

Filing date 14 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 26 March 2009

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07C 215/28 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 233/22 (2006.01) Carboxylic acid amides

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/040091 Priority application(s): WO2005/040091

26 March 2009 Application Accepted

  Published as AU-B-2004283844

23 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283845-Novel imidazole derivatives and their use as pharmaceutical agents

2004283843-Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders